|
|
Volumn 34, Issue 1, 2002, Pages 100-101
|
|
Experience with basiliximab in pediatric renal transplantation
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
GANCICLOVIR;
INTERLEUKIN 2 RECEPTOR;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
METHYLPREDNISOLONE;
ADOLESCENT;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CYTOMEGALOVIRUS INFECTION;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY ALLOGRAFT;
KIDNEY GRAFT REJECTION;
MALE;
MICROEMULSION;
PEDIATRIC SURGERY;
PRIORITY JOURNAL;
SCHOOL CHILD;
ADOLESCENT;
ANTIBODIES, MONOCLONAL;
CHILD;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
ISOANTIBODIES;
KIDNEY TRANSPLANTATION;
LYMPHOCYTES;
MALE;
METHYLPREDNISOLONE;
RECEPTORS, INTERLEUKIN-2;
RECOMBINANT FUSION PROTEINS;
RENAL DIALYSIS;
REOPERATION;
TIME FACTORS;
|
|
EID: 0036227962
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02686-0 Document Type: Article |
|
Times cited : (4)
|
|
References (12)
|
